ATE78826T1 - IN POSITION-10 BY A RADICAL WITH DOUBLE RESP. TRIPLE BONDING SUBSTITUTED STEROIDS AND PROCESS FOR THEIR MANUFACTURE. - Google Patents

IN POSITION-10 BY A RADICAL WITH DOUBLE RESP. TRIPLE BONDING SUBSTITUTED STEROIDS AND PROCESS FOR THEIR MANUFACTURE.

Info

Publication number
ATE78826T1
ATE78826T1 AT88117295T AT88117295T ATE78826T1 AT E78826 T1 ATE78826 T1 AT E78826T1 AT 88117295 T AT88117295 T AT 88117295T AT 88117295 T AT88117295 T AT 88117295T AT E78826 T1 ATE78826 T1 AT E78826T1
Authority
AT
Austria
Prior art keywords
resp
radical
manufacture
double
substituted steroids
Prior art date
Application number
AT88117295T
Other languages
German (de)
Inventor
Vesperto Torelli
Lucien Nedelec
Martine Moguilewsky
Anne-Marie Moura
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Application granted granted Critical
Publication of ATE78826T1 publication Critical patent/ATE78826T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0044—Alkenyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/005—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/006—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/007—3 membered carbocyclic rings in position 6-7

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

The intermediate products of formula (II): <IMAGE> R' = especially H or optionally substituted alkyl, alkenyl, alkynyl, aryl or aralkyl, hydroxyl, tetrahydropyranyl, tert-butoxy, optionally esterified carboxyl, amino, mono- or dialkylamino, tritylamino, chloroacetamido, trifluoroacetylamino, trichloroethoxycarbonylamino, halogen or trialkylsilyl, R2 = methyl or ethyl, and process for their preparation.
AT88117295T 1984-08-24 1985-08-22 IN POSITION-10 BY A RADICAL WITH DOUBLE RESP. TRIPLE BONDING SUBSTITUTED STEROIDS AND PROCESS FOR THEIR MANUFACTURE. ATE78826T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8413189A FR2569408B1 (en) 1984-08-24 1984-08-24 NOVEL STEROIDS SUBSTITUTED IN POSITION 10 BY A RADICAL HAVING A DOUBLE OR TRIPLE LINK, THEIR PREPARATION METHOD, THEIR APPLICATION AS MEDICAMENTS, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP88117295A EP0313960B1 (en) 1984-08-24 1985-08-22 Steroids substituted in position 10 by a radical containing a double or triple bond, and process for their preparation

Publications (1)

Publication Number Publication Date
ATE78826T1 true ATE78826T1 (en) 1992-08-15

Family

ID=9307209

Family Applications (2)

Application Number Title Priority Date Filing Date
AT88117295T ATE78826T1 (en) 1984-08-24 1985-08-22 IN POSITION-10 BY A RADICAL WITH DOUBLE RESP. TRIPLE BONDING SUBSTITUTED STEROIDS AND PROCESS FOR THEIR MANUFACTURE.
AT85401672T ATE42561T1 (en) 1984-08-24 1985-08-22 IN POSITION 10 BY A DOUBLE OR TRIPLE BOND CONTAINING RADICAL SUBSTITUTED NOVEL STEROIDS, PROCESS FOR THEIR MANUFACTURE, THEIR USE AS MEDICINES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT85401672T ATE42561T1 (en) 1984-08-24 1985-08-22 IN POSITION 10 BY A DOUBLE OR TRIPLE BOND CONTAINING RADICAL SUBSTITUTED NOVEL STEROIDS, PROCESS FOR THEIR MANUFACTURE, THEIR USE AS MEDICINES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.

Country Status (21)

Country Link
US (1) US4701449A (en)
EP (2) EP0313960B1 (en)
JP (1) JPH0649717B2 (en)
KR (1) KR940008596B1 (en)
CN (1) CN1029683C (en)
AT (2) ATE78826T1 (en)
AU (1) AU580086B2 (en)
CA (1) CA1260459A (en)
DE (2) DE3586427T2 (en)
DK (1) DK168538B1 (en)
ES (1) ES8604988A1 (en)
FI (1) FI82699C (en)
FR (1) FR2569408B1 (en)
GR (1) GR852037B (en)
HU (1) HU194276B (en)
IE (1) IE64675B1 (en)
IL (1) IL76096A (en)
MX (1) MX159930A (en)
PT (1) PT81020B (en)
SU (1) SU1470198A3 (en)
ZA (1) ZA856427B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2576025B1 (en) * 1985-01-14 1987-01-23 Roussel Uclaf NOVEL SUBSTITUTED STEROIDS IN POSITION 10, THEIR PROCESS AND THE PREPARATION INTERMEDIATES, THEIR APPLICATION AS MEDICAMENTS, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2594829B1 (en) * 1986-02-24 1988-06-03 Roussel Uclaf NEW STEROIDS 9 (11) SATURES SUBSTITUTED IN POSITION 10 BY A RADICAL COMPRISING A TRIPLE LINK, THEIR PREPARATION METHOD, THEIR APPLICATION AS MEDICAMENTS, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
WO1990002781A1 (en) * 1988-09-16 1990-03-22 Lithium Corporation Of America Thermally stable, reactive organometallic compositions containing copper
US5100575A (en) * 1989-09-08 1992-03-31 Fmc Corporation Thermally stable, reactive organometallic compositions containing copper
ES2347027T3 (en) 1998-05-22 2010-10-22 The Board Of Trustees Of The Leland Stanford Junior University BIFUNCTIONAL MOLECULES AND THERAPIES BASED ON THE SAME.
EP2671507A3 (en) 2005-04-28 2014-02-19 Proteus Digital Health, Inc. Pharma-informatics system
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
FR2917975B1 (en) * 2007-06-26 2009-10-16 Ceva Sante Animale Sa COMPOSITIONS AND TREATMENT OF CARDIAC INSUFFICIENCY IN NON-HUMAN MAMMAL ANIMALS
US20090270356A1 (en) * 2008-04-28 2009-10-29 Ceva Sante Animale Sa Compositions and treatments of heart failure in non-human mammal animals
CA2752373C (en) 2009-02-20 2017-10-10 To-Bbb Holding B.V. Glutathione-based drug delivery system
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
CN103145785B (en) * 2013-03-19 2016-03-02 浙江仙居仙乐药业有限公司 A kind of synthetic method of cyproterone acetate dehydrogen substance

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3102127A (en) * 1962-06-12 1963-08-27 Syntex Corp 19-methylene-androstane derivatives
US3218316A (en) * 1963-08-26 1965-11-16 Syntex Corp 10beta-ethynyl-19-norandrostane derivatives
US3275622A (en) * 1963-12-18 1966-09-27 Syntex Corp 19-alkylidene-delta4-3, 20-keto pregnanes
FR1519387A (en) * 1966-04-20 1968-03-29 Hoffmann La Roche Process for the preparation of 19-alkenyl steroids
FR2344286A1 (en) * 1976-03-16 1977-10-14 Roussel Uclaf NEW DERIVATIVES 17-SPIROSULTINES, THE CORRESPONDING G-HYDROXY ACIDS, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS A MEDICINAL PRODUCT
FR2462445A1 (en) * 1979-07-31 1981-02-13 Roussel Uclaf NOVEL 17 - / (HYDROXYMETHYL) (FORMAMIDO) METHYLENE / STEROID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR APPLICATION TO THE INTRODUCTION OF THE HYDROXYACETYL LATERAL CHAIN
HU179980B (en) * 1979-12-28 1983-01-28 Gyogyszerkutato Intezet Process for preparing substituted steroid-spiro-oxazolidinone derivatives
US4322416A (en) * 1980-06-27 1982-03-30 Merrell Dow Pharmaceuticals Inc. 10-Alkynyl steroids

Also Published As

Publication number Publication date
FI82699B (en) 1990-12-31
DE3586427T2 (en) 1993-01-07
IE852075L (en) 1986-02-24
JPS6176499A (en) 1986-04-18
FR2569408A1 (en) 1986-02-28
EP0313960A1 (en) 1989-05-03
DK168538B1 (en) 1994-04-18
IE64675B1 (en) 1995-08-23
DE3569739D1 (en) 1989-06-01
FI82699C (en) 1991-04-10
DK382185D0 (en) 1985-08-23
HUT39461A (en) 1986-09-29
IL76096A0 (en) 1985-12-31
DE3586427D1 (en) 1992-09-03
PT81020A (en) 1985-09-01
EP0313960B1 (en) 1992-07-29
DK382185A (en) 1986-02-25
ATE42561T1 (en) 1989-05-15
IL76096A (en) 1989-09-10
EP0176399B1 (en) 1989-04-26
ES8604988A1 (en) 1986-03-01
FI853254A0 (en) 1985-08-23
ZA856427B (en) 1986-10-29
CN1029683C (en) 1995-09-06
KR860001824A (en) 1986-03-22
SU1470198A3 (en) 1989-03-30
AU4662585A (en) 1986-02-27
KR940008596B1 (en) 1994-09-24
HU194276B (en) 1988-01-28
CN85106995A (en) 1987-04-01
GR852037B (en) 1985-12-18
MX159930A (en) 1989-10-06
EP0176399A1 (en) 1986-04-02
ES546372A0 (en) 1986-03-01
CA1260459A (en) 1989-09-26
JPH0649717B2 (en) 1994-06-29
US4701449A (en) 1987-10-20
FI853254L (en) 1986-02-25
AU580086B2 (en) 1988-12-22
FR2569408B1 (en) 1986-10-03
PT81020B (en) 1987-12-30

Similar Documents

Publication Publication Date Title
ATE78826T1 (en) IN POSITION-10 BY A RADICAL WITH DOUBLE RESP. TRIPLE BONDING SUBSTITUTED STEROIDS AND PROCESS FOR THEIR MANUFACTURE.
PL292455A1 (en) Method of obtaining novel derivatives of erythromycin
ATE145649T1 (en) CARDIOACTIVE 17-ARYL AND 17-HETEROCYCLYL-14 BETA-5ALPHA-ANDROSTANE, ANDROSTENES AND ANDROSTADIENES, A METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS THEREOF
FI942944L (en) New 19-nor steroids having a thiocarbon chain in the 11beta position, a method for their preparation and intermediates of this method, their use as medicaments and compositions
ATE90676T1 (en) DIOXYALKYLENARYL-DIHYDROPYRIDINE INTERMEDIATE PRODUCTS FOR THEIR PREPARATION, PROCESS FOR THEIR PREPARATION AND THEIR USE.
ATE136035T1 (en) STEROID DERIVATIVES CARRYING A SUBSTITUTED THIOETHYL RADICAL IN PLACE 10 OF THE STEROID, METHOD FOR THE PRODUCTION THEREOF AND INTERMEDIATE PRODUCTS THEREOF, THEIR USE AS MEDICINAL PRODUCTS AND PHARMACEUTICAL PREPARATIONS THEREOF
DE69402114D1 (en) New 19-nor steroids with an 11-beta-phenoxysulfonamide or 11-beta-phenoxysulfonylurea group, processes and intermediates for their manufacture, and medicines and pharmaceutical preparations thereof
DE3873870D1 (en) ANDROSTAN-17-CARBONIC ACID ESTER, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING IT.
ATE67182T1 (en) NEW CARBACYCLINES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS MEDICINES.
ATE154031T1 (en) 8-EN-19, 11 BETA-BRIDGED STEROIDS, THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
ATE152118T1 (en) CARDIOACTIVE 17B-(3-FURYL) AND 17B-(4-PYRIDAZINYL)-5BETA, 14BETA-ANDROSTANE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS THEREOF
DE69314570D1 (en) Process for the preparation of taurine-conjugated bile acid
EP0186023A3 (en) Biliary acid derivatives, process for their preparation and pharmaceutical compositions containing them
DE3765611D1 (en) METHOD FOR PRODUCING A FINE-GRAIN RECRISTALLIZED SHEET.
AU3088984A (en) Antibodies and compositions thereof for inhibiting dental induced by s. abitans
ATE63920T1 (en) NEW N-GLYCOSYLAMIDE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS.
ATE111894T1 (en) PROCESS FOR THE PREPARATION OF CLAUSENAMID AND NEOCLAUSENAMID AND THEIR DERIVATIVES.
FR2516519B1 (en) PROCESS FOR THE PREPARATION OF A CORTICOID FROM AN UNSATURATED STEROID IN POSITION 20
DE69116234D1 (en) Process for the preparation of cyclohexyl acetate
ATE17570T1 (en) NEW 1,1,2-TRIPHENYL-BUT-1-EN DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS.
ATE67997T1 (en) METHYL-3,3-DIALKOXY-1-PROPYL-PHOSPHINE ACID ESTERS THE CORRESPONDING 3- OXO COMPOUNDS AND A PROCESS FOR THEIR PREPARATION.
DE3764330D1 (en) 2,2; 6,6-DIETHYLENE-3-OXO-17ALPHA-PREGN-4-EN-21, 17-CARBOLACTONE, METHOD FOR THE PRODUCTION THEREOF AND THE PHARMACEUTICAL CONTAINING THEM. PREPARATIONS.
DE69116198D1 (en) Process for the preparation of D-isocitric acid by fermentation
ATE63315T1 (en) STEROIDS BEARING A KETO GROUP AT POSITION 23, PROCESSES FOR THEIR PREPARATION, THEIR USE IN THE PREPARATION OF 20-KETOPREGN SERIES COMPOUNDS, AND INTERMEDIATE PRODUCTS FOR SUCH USE.
JPS5346984A (en) Oxazolidine derivatives

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee